Best Vascular Endothelial Growth Factor Inhibitor for retinal vein occlusion
The 2 Vascular Endothelial Growth Factor Inhibitor options we list for retinal vein occlusion are all Ranibizumab— the same active ingredient in different brands or formulations, so they aren’t ranked against each other on effectiveness. Our score reflects each product’s FDA recall-safety record; the practical choice is brand vs generic, dose, and cost. Compare them with all treatments for retinal vein occlusion or the full Vascular Endothelial Growth Factor Inhibitor class. Not medical advice — always consult a professional.
Quick answer: Of the 2 vascular endothelial growth factor inhibitor drugs we rate for retinal vein occlusion, none are yet flagged as generics in our price data, and most are injectable. Our ranking reflects each drug’s FDA recall-safety record — not clinical effectiveness for retinal vein occlusion; the right choice depends on your situation, so confirm it with your prescriber.
How vascular endothelial growth factor inhibitor work
VEGF inhibitors block VEGF, the signal that tells the body to grow new blood vessels. By soaking up or blocking this signal, they starve tumors of the new vessels they need to grow, or calm the leaky abnormal vessels that damage the retina in eye diseases.
These are all Ranibizumabin different brands or formulations, so we don’t rank them against each other — the list below is for comparing brand vs generic, dose, and typical cost, not for picking a “best” one on effectiveness.
All 2 vascular endothelial growth factor inhibitor products
lucentis
PrescriptionFDA-sourced
Lucentis (Ranibizumab) is a vascular endothelial growth factor inhibitor used to treat Diabetic Retinopathy, Macular Edema, Retinal Vein Occlusion.
Price varies
susvimo
Boxed warningPrescriptionFDA-sourced
Susvimo (Ranibizumab) is a vascular endothelial growth factor inhibitor used to treat Diabetic Retinopathy, Macular Edema, Retinal Vein Occlusion.
Price varies
Frequently asked
- What is the best vascular endothelial growth factor inhibitor for retinal vein occlusion?
- The Vascular Endothelial Growth Factor Inhibitor options we list for retinal vein occlusion are all Ranibizumab — the same active ingredient in different brands or formulations — so there's no single "best" one on effectiveness; the practical choice is brand vs generic, dose, and cost. Always consult a professional.
- Which vascular endothelial growth factor inhibitor drugs treat retinal vein occlusion?
- pharmaranks lists 2 Vascular Endothelial Growth Factor Inhibitor products used for retinal vein occlusion, per NIH RxClass drug-classification data — each independently rated and ranked above.
- How are these ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.